CIDRAP newsletters options
No flu vaccine in Nigeria after first H1N1 death
Jan 20, 2010
Jan 19, 2010
(CIDRAP News) The H1N1 influenza pandemic brought no "devastating surprises," but what has surprised public health agencies is the public's lack of interest in getting vaccinated, Margaret Chan, director-general of the World Health Organization (WHO), said yesterday.
GSK vaccine sales lower than predicted
(CIDRAP News) The use of adjuvanted vaccines, an unfamiliar technology, helped spark mistrust that may have contributed to the recent allegations in Europe that pharmaceutical companies manipulated governments and international agencies by hyping the H1N1 pandemic threat, according to a British market analyst who follows infectious disease issues.
(CIDRAP News) During a week federal officials set aside to push flu immunization, a new report today reveals that pandemic vaccine uptake is low in two of the top priority groupsthose with chronic conditions and healthcare workers.
The report outlining the challenges public health officials face in vaccinating target groups came as federal officials released their latest estimates of pandemic flu cases, hospitalizations, and deaths.
Jan 14, 2010
(CIDRAP News) – The World Health Organization (WHO) and vaccine makers from Europe today defended themselves against the charges of some European officials that the agency was improperly influenced by vaccine companies and exaggerated the threat of the pandemic H1N1 virus.
Jan 13, 2010
(CIDRAP News) Leading public health officials and experts have sharply rejected charges from some European officials that pharmaceutical companies used exaggerated claims about the H1N1 pandemic threat to scare governments into buying unnecessary stockpiles of vaccines.
Jan 12, 2010
(CIDRAP News) Federal officials and representatives from some of the nation's biggest health advocacy groups today teamed up to push the importance of pandemic H1N1 vaccination for people who have chronic medical conditions such as asthma, diabetes, and cancer.
(CIDRAP News) The US government recently cut back its contract for H1N1 influenza vaccine from Australian-based CSL Biotherapies by about 60%, mainly as a result of delays related to the company's commitment to make vaccine for Australia first.
Jan 11, 2010
Jan 8, 2009 (CIDRAP News) Only one state, Alabama, still had widespread pandemic H1N1 influenza activity last week, down from four the week before, and most other flu indicators were down as well, the Centers for Disease Control and Prevention (CDC) said today.
Mongolia is first country to get donated vaccine
